ArticlePloS one2023

Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies.

Tagyedeen H Shoaib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.